Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07213986 · ClinicalTrials.gov registry record · NA

Vibrant Capsule for Spinal Cord Injury Neurogenic Bowel Dysfunction

A NA study of Spinal Cord Injury and Neurogenic Bowel Dysfunction, sponsored by The University of Texas Health Science Center, Houston.

Recruiting
Registry status
NA
Development phase
12
Enrollment target
1
Study location

NCT07213986 is a NA study of Spinal Cord Injury and Neurogenic Bowel Dysfunction that is actively recruiting participants, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 12 participants, below the 86-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07213986, a NA study of Spinal Cord Injury and Neurogenic Bowel Dysfunction, is actively recruiting participants, sponsored by The University of Texas Health Science Center, Houston.

RECRUITING
Registry status
NA
Development phase
12 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to test the safety and effectiveness of Vibrant capsules in spinal cord injury patients with neurogenic bowel.

Interventions

  • DEVICE Vibrant Capsule

Study Locations (1)

Texas

  • TIRR Memorial Hermann - Houston

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2026-01-06
Est. Completion 2026-03-01
Phase NA

What the Registry Record Tells You About NCT07213986

The ClinicalTrials.gov registry entry for NCT07213986 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 86-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (86% lower). The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Spinal Cord Injury appearing as the primary indexed condition, and to 1 intervention - of which Vibrant Capsule is the first listed.

NCT07213986 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT07213986 about?

NCT07213986 is a clinical study titled "Vibrant Capsule for Spinal Cord Injury Neurogenic Bowel Dysfunction". The goal of this study is to test the safety and effectiveness of Vibrant capsules in spinal cord injury patients with neurogenic bowel.

What is the current status of trial NCT07213986?

This trial is currently recruiting. It is a NA study. The enrollment target is 12 participants. The study started on 2026-01-06. Estimated completion is 2026-03-01.

What conditions does trial NCT07213986 study?

This clinical trial studies the following conditions: Spinal Cord Injury, Neurogenic Bowel Dysfunction.

What interventions are being tested in trial NCT07213986?

The interventions under investigation include: Vibrant Capsule (DEVICE).

Who is sponsoring clinical trial NCT07213986?

This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07213986 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spinal Cord Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.